These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 26512116)

  • 1. HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells.
    Zhang H; Lu H; Xiang L; Bullen JW; Zhang C; Samanta D; Gilkes DM; He J; Semenza GL
    Proc Natl Acad Sci U S A; 2015 Nov; 112(45):E6215-23. PubMed ID: 26512116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy induces enrichment of CD47
    Samanta D; Park Y; Ni X; Li H; Zahnow CA; Gabrielson E; Pan F; Semenza GL
    Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1239-E1248. PubMed ID: 29367423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer.
    Kaur S; Elkahloun AG; Singh SP; Chen QR; Meerzaman DM; Song T; Manu N; Wu W; Mannan P; Garfield SH; Roberts DD
    Oncotarget; 2016 Mar; 7(9):10133-52. PubMed ID: 26840086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
    Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
    Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD47 Blockade Inhibits Tumor Progression through Promoting Phagocytosis of Tumor Cells by M2 Polarized Macrophages in Endometrial Cancer.
    Gu S; Ni T; Wang J; Liu Y; Fan Q; Wang Y; Huang T; Chu Y; Sun X; Wang Y
    J Immunol Res; 2018; 2018():6156757. PubMed ID: 30525058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells.
    Xiang L; Gilkes DM; Hu H; Luo W; Bullen JW; Liang H; Semenza GL
    Oncotarget; 2015 May; 6(14):11768-78. PubMed ID: 26059435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of glyceraldehyde-3-phosphate dehydrogenase gene expression by HIF-1 activity depending on Sp1 in hypoxic breast cancer cells.
    Higashimura Y; Nakajima Y; Yamaji R; Harada N; Shibasaki F; Nakano Y; Inui H
    Arch Biochem Biophys; 2011 May; 509(1):1-8. PubMed ID: 21338575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression.
    Luo W; Chang R; Zhong J; Pandey A; Semenza GL
    Proc Natl Acad Sci U S A; 2012 Dec; 109(49):E3367-76. PubMed ID: 23129632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CD47 and leukemia stem cells].
    Cheng QS; Wang XB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1088-91. PubMed ID: 20723335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer.
    Yoshida K; Tsujimoto H; Matsumura K; Kinoshita M; Takahata R; Matsumoto Y; Hiraki S; Ono S; Seki S; Yamamoto J; Hase K
    Cancer Med; 2015 Sep; 4(9):1322-33. PubMed ID: 26077800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-induced ZEB1 promotes cervical cancer immune evasion by strengthening the CD47-SIRPα axis.
    Chen XJ; Guo CH; Wang ZC; Yang Y; Pan YH; Liang JY; Sun MG; Fan LS; Liang L; Wang W
    Cell Commun Signal; 2024 Jan; 22(1):15. PubMed ID: 38183060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human HIF (hypoxia-inducible factor)-3alpha gene is a HIF-1 target gene and may modulate hypoxic gene induction.
    Tanaka T; Wiesener M; Bernhardt W; Eckardt KU; Warnecke C
    Biochem J; 2009 Oct; 424(1):143-51. PubMed ID: 19694616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer.
    Betancur PA; Abraham BJ; Yiu YY; Willingham SB; Khameneh F; Zarnegar M; Kuo AH; McKenna K; Kojima Y; Leeper NJ; Ho P; Gip P; Swigut T; Sherwood RI; Clarke MF; Somlo G; Young RA; Weissman IL
    Nat Commun; 2017 Apr; 8():14802. PubMed ID: 28378740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo.
    Zhang M; Hutter G; Kahn SA; Azad TD; Gholamin S; Xu CY; Liu J; Achrol AS; Richard C; Sommerkamp P; Schoen MK; McCracken MN; Majeti R; Weissman I; Mitra SS; Cheshier SH
    PLoS One; 2016; 11(4):e0153550. PubMed ID: 27092773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment.
    Iwamoto C; Takenaka K; Urata S; Yamauchi T; Shima T; Kuriyama T; Daitoku S; Saito Y; Miyamoto T; Iwasaki H; Kitabayashi I; Itoh K; Kishimoto J; Kohda D; Matozaki T; Akashi K
    Exp Hematol; 2014 Mar; 42(3):163-171.e1. PubMed ID: 24269920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells.
    Samanta D; Gilkes DM; Chaturvedi P; Xiang L; Semenza GL
    Proc Natl Acad Sci U S A; 2014 Dec; 111(50):E5429-38. PubMed ID: 25453096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factor 1 and breast cancer metastasis.
    Liu ZJ; Semenza GL; Zhang HF
    J Zhejiang Univ Sci B; 2015 Jan; 16(1):32-43. PubMed ID: 25559953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NDR1 activates CD47 transcription by increasing protein stability and nuclear location of ASCL1 to enhance cancer stem cell properties and evasion of phagocytosis in small cell lung cancer.
    Wang LL; Wan XY; Wang TL; Liu CQ; Zheng FM
    Med Oncol; 2022 Oct; 39(12):254. PubMed ID: 36224405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of osteopontin promotes the radiosensitivity of breast cancer cells by reducing the expression of hypoxia inducible factor 1 and vascular endothelial growth factor.
    Yang L; Zhao W; Zuo WS; Wei L; Song XR; Wang XW; Zheng G; Zheng MZ
    Chin Med J (Engl); 2012 Jan; 125(2):293-9. PubMed ID: 22340562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-dependent leptin expression in breast cancer cells.
    Bartella V; Cascio S; Fiorio E; Auriemma A; Russo A; Surmacz E
    Cancer Res; 2008 Jun; 68(12):4919-27. PubMed ID: 18559540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.